| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
10% Owner | Director | Director, 10% Owner
10 companies
Ecor1 Capital, LLC is a 10% Owner at ADAPY with holdings across 10 companies. Recent SEC Form 4 filings include 12 buys and 5 sells.
Estimated insider holdings value: $1503.5M based on current market prices.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Jun 16, 2023 | ZYME Zymeworks Inc. | 10% Owner | Buy | 3,350,000 | $8.12 | $27,202,000.00 | +33.2% | -16.5% | +11.3% | |
| Mar 28, 2023 | ZYME Zymeworks Inc. | - | Buy | 200,000 | $8.00 | $1,600,000.00 | +2.0% | -2.1% | +27.6% | |
| Jan 20, 2023 | ZYME Zymeworks Inc. | 10% Owner | Buy | 307,500 | $9.70 | $2,982,733.31 | +1.6% | -1.7% | -1.2% | |
| Jan 18, 2023 | ZYME Zymeworks Inc. | 10% Owner | Buy | 985,100 | $9.84 | $9,697,526.50 | +3.7% | -0.2% | -1.4% | |
| Jan 11, 2023 | ZYME Zymeworks Inc. | 10% Owner | Buy | 1,026,300 | $7.67 | $7,874,082.53 | +6.4% | +9.2% | +33.1% | |
| Jan 11, 2023 | VYGR Voyager Therapeutics, Inc. | 10% Owner | Sell | 902,400 | $7.91 | $7,142,343.08 | -6.9% | -10.8% | -10.6% | |
| Jun 23, 2022 | VYGR Voyager Therapeutics, Inc. | 10% Owner | Buy | 477,400 | $5.58 | $2,662,046.74 | +5.5% | +3.6% | +104.3% | |
| May 5, 2022 | ANAB Anaptysbio, Inc | 10% Owner | Sell | 668,237 | $21.63 | $14,453,966.31 | -8.2% | -2.9% | +1.2% | |
| May 5, 2022 | PRTA Prothena Corp Public Ltd Co | 10% Owner | Sell | 1,062,736 | $29.02 | $30,840,598.72 | -8.4% | +6.5% | +170.8% | |
| May 5, 2022 | PRTA Prothena Corp Public Ltd Co | 10% Owner | Buy | 1,062,736 | $29.02 | $30,840,598.72 | +10.1% | +6.5% | +170.8% |